Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chen

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Cancer Chemotherapy and Pharmacology|January 24, 2023
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivoMüge Sak, Brian J Williams, Cory T Zumbar, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 12, 2023
MicroRNA-29a: a novel target for non-operative management of symptomatic lumbar spinal stenosisRichard A Wawrose, Anthony A Oyekan, Yunting Melissa Tang, et al.
Nature Communications|January 12, 2022
Breaking constraint of mammalian axial formulaeGabriel M Hauswirth, Victoria C Garside, Lisa S F Wong, et al.
Stem Cells (Dayton, Ohio)|February 4, 2018
Fine Tuning of Canonical Wnt Stimulation Enhances Differentiation of Pluripotent Stem Cells Independent of β-Catenin-Mediated T-Cell Factor SignalingJoseph Chen, Christian M Nefzger, Fernando J Rossello, et al.
Biochimica Et Biophysica Acta|January 24, 2012
Investigation into the role of phosphatidylserine in modifying the susceptibility of human lymphocytes to secretory phospholipase A(2) using cells deficient in the expression of scramblaseJennifer Nelson, Lyndee L Francom, Lynn Anderson, et al.
The Lancet. Oncology|October 28, 2017
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trialAlice T Shaw, Enriqueta Felip, Todd M Bauer, et al.
Cancers|January 19, 2020
Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care ClinicDavid Hui, Eman Abdelghani, Joseph Chen, et al.
Journal of Virology|August 27, 2025
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strainsMatthew J Gartner, Monique L Smith, Clyde Dapat, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Discovery of potent iminoheterocycle BACE1 inhibitorsJohn P Caldwell, Robert D Mazzola, James Durkin, et al.
Clinical Pharmacokinetics|December 11, 2023
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung CancerJoseph Chen, Alessandra Bearz, Dong-Wan Kim, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|January 24, 2023
The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivoMüge Sak, Brian J Williams, Cory T Zumbar, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 12, 2023
MicroRNA-29a: a novel target for non-operative management of symptomatic lumbar spinal stenosisRichard A Wawrose, Anthony A Oyekan, Yunting Melissa Tang, et al.
Nature Communications|January 12, 2022
Breaking constraint of mammalian axial formulaeGabriel M Hauswirth, Victoria C Garside, Lisa S F Wong, et al.
Stem Cells (Dayton, Ohio)|February 4, 2018
Fine Tuning of Canonical Wnt Stimulation Enhances Differentiation of Pluripotent Stem Cells Independent of β-Catenin-Mediated T-Cell Factor SignalingJoseph Chen, Christian M Nefzger, Fernando J Rossello, et al.
Biochimica Et Biophysica Acta|January 24, 2012
Investigation into the role of phosphatidylserine in modifying the susceptibility of human lymphocytes to secretory phospholipase A(2) using cells deficient in the expression of scramblaseJennifer Nelson, Lyndee L Francom, Lynn Anderson, et al.
The Lancet. Oncology|October 28, 2017
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trialAlice T Shaw, Enriqueta Felip, Todd M Bauer, et al.
Cancers|January 19, 2020
Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care ClinicDavid Hui, Eman Abdelghani, Joseph Chen, et al.
Journal of Virology|August 27, 2025
Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strainsMatthew J Gartner, Monique L Smith, Clyde Dapat, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Discovery of potent iminoheterocycle BACE1 inhibitorsJohn P Caldwell, Robert D Mazzola, James Durkin, et al.
Clinical Pharmacokinetics|December 11, 2023
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung CancerJoseph Chen, Alessandra Bearz, Dong-Wan Kim, et al.
Pageof 19